Xalud is derived from the word,
salud, expressing ‘safety’ in Latin
and ‘health’ in Spanish
Founded in 2009 by three experienced scientists who joined forces to develop treatments for chronic inflammatory disease, Xalud Therapeutics is a non-viral gene therapy company targeting immune modulation. Xalud’s mission is to harness the power of interleukin-10 (IL-10), a potent anti-inflammatory cytokine, to address the root cause of inflammation and subsequently restore homeostasis in the immune system.